What Do Analysts Think Of Fractyl Health Inc (GUTS)

Fractyl Health Inc (GUTS) saw an uptrend of 4.36% in the recent trading with $1.02 being its most recent. The current price level -72.58% lower than the highest price of $3.72 marked by the stock while trading over the past 52-weeks, whereas it is 23.64% higher than the lowest price of $0.82 the company dropped to over past 52-weeks. The latest news story on GUTS appeared in (GuruFocus.com) under the title “Fractyl Health Inc (GUTS) Q2 2025 Earnings Call Highlights: Financial Discipline and Promising..” on.

Squeezing the time span to 30 day period shows us the stock is currently trading -51.43% below one month high and is +23.64% above of the lowest during that time. Looking into the simple moving average, Fractyl Health Inc (GUTS)’s stock stands at a SMA-50 of $1.6936 while that of 5-day is reading $0.9937.

Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and GUTS’s SMA-200 as of now is $1.7507.

Do analysts rate it as a buy, sell or hold?

Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 1 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.

Fractyl Health Inc Earnings – What Happened With GUTS

Coming around sales and income figures on GUTS Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Fractyl Health Inc (GUTS) last released financial results for the quarter that ended 9/30/2024, posting a surprise factor of 14.28% for net revenue.

GUTS – Fractyl Health Inc Stock Earnings Estimates

The perspective of Fractyl Health Inc (NASDAQ:GUTS)’s current quarter earnings identifies that analysts are in consensus over the estimate of -0.5 for stock’s EPS in the current quarter. Fractyl Health Inc (GUTS) last released financial results for the quarter that ended 9/30/2024, posting a surprise factor of 14.28% for net revenue. Company’s EPS for the last quarter was -0.43.

Fractyl Health Inc – Insider Activity and Holdings

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 49.92 million. GUTS does have institutional investors; and they hold 19.37% of the stock.

As on 2024-06-30, DEER MANAGEMENT CO. LLC was the top most holder in Fractyl Health Inc (NASDAQ:GUTS) with an ownership of 4.77 million shares of the company or 9.9603 of the stake worth $20.37 million. The filing also reveals HCC MANAGER LLC as the second largest holder in the company with a control over 9.7577 of the outstanding shares. Its stake is worth $34.59 million for having 4.67 million shares in hand.

MAVERICK CAPITAL LTD also came holding a key position in the company during the recent quarter and it now holds 8.8825 of the outstanding shares. With this there are now 77.0 institutions which have possession in GUTS’s shares.

Key Metrics forGUTS

Technical Analysis of Fractyl Health Inc (NASDAQ:GUTS) stock

To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Fractyl Health Inc (GUTS), we notice that the stock’s 20-day average volume is at 1,224,655 shares and 100% of short term indicators are suggesting the stock as Sell. Its 50-day average volume of 922,636 shares. And to end, GUTS’s 100-day average volume is 589,725 shares with 100% of the long-term indicators pointing towards Sell for the stock.

The Baxter Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.